一种用于克服非小细胞肺癌治疗中抗原异质性的多靶向 CAR-T 细胞平台
A Multi-Targeting Chimeric Antigen Receptor-T Cell Platform to Overcome Antigen Heterogeneity in the Treatment of Non-Small Cell Lung Cancer.
这些发现支持采用多靶点CAR-T 策略来应对NSCLC及可能其他实体瘤中的抗原异质性。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Comprehensive analysis of PD-L1 expression, tumor-infiltrating lymphocytes, and tumor microenvironment in LUAD: differences between Asians and Caucasians.
Comprehensive analysis of PD-L1 expression, tumor-infiltrating lymphocytes, and tumor microenvironment in LUAD: differences between Asians and Caucasians.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
白人与亚洲 LUAD 患者在 PD-L1 表达、TILs 和 TME 特征方面存在许多差异。这为分别针对白人及亚洲 LUAD 患者选择特异性免疫治疗策略提供了一定提示。
肺腺癌(LUAD)患者中程序性细胞死亡蛋白-1(PD-L1)表达、TIL(肿瘤浸润淋巴细胞)(TILs)及肿瘤微环境(TME)的特征与免疫治疗密切相关,且在亚洲人与白种人之间存在差异。
获取癌症基因组图谱和中国LUAD患者的转录组数据。使用R软件分析基因的差异表达、预后和基因功能。使用CIBERSORT进行TIL相关分析,使用ESTIMATE进行TME相关分析。
高加索LUAD患者肿瘤组织中PD-L1的表达低于正常组织,而亚洲人中没有显著差异。PD-L1表达与预后之间没有统计学差异。高加索和亚洲LUAD患者之间TILs的组成有相当大的差异。在高加索人中,TILs与预后之间没有相关性。然而,静息肥大细胞含量较高表明亚洲人的预后较好。免疫评分和estimate评分较高的高加索患者预后较好(p = 0.021,p = 0.025)。然而,estimate评分较高的亚洲患者预后较差(p = 0.024)。COL5A2(p = 0.046,p = 0.027)和NOX4(p = 0.020,p = 0.019)的高表达均与高加索人和亚洲人的不良预后相关。
Acquire the transcriptome data of the Cancer Genome Atlas and Chinese LUAD patients. R software was used to analyze the differential expression of genes, prognosis, and gene function. Use CIBERSORT for TIL-related analysis and ESTIMATE for TME-related analysis.
The expression of PD-L1 in tumor tissues of Caucasian LUAD patients was lower than that in normal tissues, while there was no significant difference in Asians. There was no statistical difference between PD-L1 expression and prognosis. The composition of TILs between Caucasian and Asian LUAD patients was quite different. There was no correlation between TILs and prognosis in Caucasians. However, the higher content of resting mast cells indicated a better prognosis in Asians. The Caucasian patients with higher immune and estimate scores had a better prognosis (p = 0.021, p = 0.025). However, the Asian patients with a higher estimate score had a worse prognosis (p = 0.024). The high expression of COL5A2 (p = 0.046, p = 0.027) and NOX4 (p = 0.020, p = 0.019) were both associated with the poor prognosis in Caucasians and Asians.
There are many differences in the characteristics of PD-L1 expression, TILs, and TME between Caucasian and Asian LUAD patients. This provides a certain hint for the selection of specific immunotherapy strategies separately for Caucasian and Asian LUAD patients.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。